Abstract
HIV counseling and testing services are critical for individuals to access HIV prevention and treatment. Unfortunately, the standard HIV testing algorithm is complex and includes the use of a sensitive enzyme immunoassay (EIA), followed by a Western blot if the EIA is positive. This process can take 1 week or longer. Therefore, innovative approaches that incorporate simpler diagnostic algorithms are needed to reach the large number of individuals who are not aware that they are HIV-infected. Currently available rapid HIV tests have demonstrated sensitivities and specificities comparable to those of standard HIV testing without the requirements of sophisticated laboratory resources or highly trained personnel. These rapid HIV tests are increasingly being used in various clinical scenarios to decrease the number of missed opportunities for detection of HIV-infection. Their use is particularly applicable in specific clinical and nonclinical settings; public health settings; labor and delivery wards; in the management of occupational exposures; and in resource-constrained settings. The overarching goals of achieving wide implementation of rapid HIV tests are to increase the number of individuals who are aware of their serostatus, to improve entry of persons with HIV into prevention and care services, and to prevent further HIV transmission
Similar content being viewed by others
References and Recommended Reading
Centers for Disease Control and Prevention: Advancing HIV prevention: new strategies for a changing epidemic — United States, 2003. MMWR 2003, 52:329–332. This article outlines the HIV prevention strategies of the CDC.
Bechwith CG, Flanigan TP, del Rio C, et al.: It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis 2005, 40:1037–1040. This article supports the use of routine HIV testing.
Update: HIV counseling and testing using rapid tests — United States, 1995. MMWR Morb Mortal Wkly Rep 1998, 47:211–215.
Branson BM: Point-of-care rapid tests for HIV antibodies. J Lab Med 2003, 27:288–295.
Lubelchek R, Kroc K, Hota B, et al.: The role of rapid vs conventional human immunodeficiency virus testing for inpatients: effects on quality of care. Arch Intern Med 2005, 165:1956–1960.
Liang TS, Erbelding E, Jacob CA, et al.: Rapid HIV testing of clients of a mobile STD/HIV clinic. AIDS Patient Care STDS 2005, 19:253–257.
Keenan PA, Keenan JM, Branson BM: Rapid HIV testing. Wait time reduced from days to minutes. Postgrad Med 2005, 117:47–52. An excellent review that explains the various rapid HIV tests.
Squire SB, Elford J, Bor R, et al.: Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ 1991, 302:1383–1386.
Centers for Disease Control and Prevention: Rapid HIV Testing: 2003 Update. http://www.cdc.gov/hiv/rapid_testing/ materials/USCA_Branson.pdf. Accessed August 4, 2006.
Ekwueme DU, Pinkerton SD, Holtgrave DR, Branson BM: Cost comparison of three HIV counseling and testing technologies. Am J Prevent Med 2003, 25:112–121.
Stringer JSA, Rouse DJ: Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a costeffectiveness analysis. Obstet Gynecol 1999, 94:34–40.
Global Programme on AIDS: Recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1992, 67:145–149.
Joint United Nations Progamme on HIV/AIDS: The importance of simple/rapid assays in HIV testing. Wkly Epidemiol Rec 1998, 73:321–328.
Centers for Disease Control and Prevention: Notice to readers: protocols for confirmation of reactive rapid HIV tests. MMWR 2004, 53:221–222.
Centers for Disease Control and Prevention: Notice to readers: approval of a new rapid test for HIV antibody. MMWR 2002, 51:1051–1052.
Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. MMWR 2001, 51:1–57.
Centers for Disease Control and Prevention: Ora-Quick rapid HIV test for oral fluid — frequently asked questions. http://www.cdc.gov/hiv/rapid_testing/materials/oral.uidqanda.n1_1.pdf. Accessed August 4, 2006.
Gaydos CA: Rapid tests for sexually transmitted diseases. Curr Infect Dis Rep 2006, 8:115–124.
Greenwald JL, Burstein JR, Pincus J, Branson B: A rapid review of rapid antibody tests. Curr Infect Dis Rep 2006, 8:125–131. Concise review of currently available FDA-approved rapid HIV tests.
Centers for Disease Control and Prevention: Routinely recommended HIV testing at an urban urgent-care clinic — Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001, 50:538–541.
Kendrick SR, Kroc KA, Withum D, et al.: Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr 2005, 38:142–146.
Hutchinson AB, Corbie-Smith G, Thomas SB, et al.: Understanding the patient‘s perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Educ Prev 2004, 16:101–114.
Valdiserri RO, Moore M, Gerber AR, et al.: A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993, 108:12–18.
Liddicoat RV, Horton NJ, Urban R, et al.: Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 2004, 19:349–356.
Tao G, Branson BM, Kessler WJ, Cohen RA: Rates of receiving HIV test results: data from the US National Health interview Survey for 1994 and 1995. J Acquir Immune Defic Syndr 1999, 22:395–400.
Kassler WJ, Dillon BA, Haley C, et al.: On-site, rapid HIV testing with same-day results and counseling. AIDS 1997, 11:1045–1051.
Kelen GD, Shahan JB, Quinn TC: Emergency departmentbased HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 1999, 33:147–154.
Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795–802.
Kourtis AP, Bulterys M, Nesheim SR, Lee FK: Understanding the timing of HIV transmission from mother to infant. JAMA 2001, 285:709–712.
Centers for Disease Control and Prevention: Rapid HIV-1 antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 2004.
Malonza IM, Richardson BA, Kreiss JK, et al.: The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial. AIDS 2003, 17:113–118.
Centers for Disease Control and Prevention: HIV testing among pregnant women — United States and Canada, 1998–2001. MMWR 2002, 51:1013–1016.
Peters V, Liu KL, Dominguez K, et al.: Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996–2000, pediatric spectrum of HIV disease cohort. Pediatrics 2003, 111:1186–1191.
Aaron E, Levine AB, Monahan K, et al.: A rapid HIV testing program for labor and delivery in an inner-city teaching hospital. AIDS Read 2006, 16:22–24.
Forsyth BW, Barringer SR, Walls TA, et al.: Rapid HIV testing of women in labor: too long a delay. J Acquir Immune Defic Syndr 2004, 35:151–154.
Bulterys M, Jamieson DJ, O‘Sullivan MJ, et al.: Motherinfant Rapid Intervention at Delivery (MIRIAD) Study Group. Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004, 292:219–223. Multicenter study that evaluated the clinical use of rapid HIV testing during labor and delivery.
Centers for Disease Control and Prevention: Rapid point-ofcare testing for HIV-1 during labor and delivery — Chicago, Illinois, 2002. MMWR 2003, 52:866–868.
Stetler HC, Granade TC, Nunez CA, et al.: Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997, 11:369–375.
Joint United Nations Programme on HIV/AIDS (UNAIDS)-World Health Organization: Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997, 72:81–87.
Kline RL, Dada A, Blattner W, Quinn TC: Diagnosis and differentiation of HIV-1 and HIV-2 infection by two rapid assays in Nigeria. J Acquir Immune Defic Syndr 1994, 7:623–626.
World Health Organization: The importance of simple and rapid tests in HIV diagnostics; WHO recommendations. Wkly Epidemiol Rec 1998, 73:321–328.
World Health Organization: Rapid HIV tests: guidelines for use in HIV testing and counseling services in resource-constrained settings. Geneva: World Health Organization; 2004.
Glick NR, Silva A, Zun L, Whitman S: HIV testing in a resource-poor urban emergency department. AIDS Educ Prev 2004, 16:126–136.
Branson BM: Rapid tests for HIV antibody. AIDS Reviews 2000, 2:76–83.
World Health Organization, Centers for Disease Control and Prevention, Association of Public Health Laboratories: Guidelines for appropriate evaluations of HIV testing technologies in Africa. Atlanta: Centers for Disease Control and Prevention; 2003.
Carvalho MB, Hamerschlak N, Vaz RS, Ferreria OC Jr: Risk factor analysis and serological diagnosis of HIV-1/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organization strategy for HIV testing. AIDS 1996, 10:1135–1140.
Wilkinson D, Wilkinson N, Lombard C: On site HIV testing in resource-poor settings: is one rapid test enough? AIDS 1997, 11:377–381.
Andersson S, da Silva Z, Norrgren H, et al.: Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infection in an HIV-1 and HIV-2-prevalent area. AIDS 1997, 11:1815–1822.
Meda N, Gautier-Charpentier L, Soudre RB, et al.: Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits. Bull World Health Organization 1999, 77:731–739.
Centers for Disease Control and Prevention: Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001, 50:1–42.
Cardo DM, Culver DH, Ciesielski CA, et al.: A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Needlestick surveillance group. N Engl J Med 1997, 337:1485–1490.
Gerberding JL: Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994, 170:1410–1417.
Bansberg D, Goldschmidt RH: Postexposure prophylaxis for occupational exposure to HIV. JAMA 1999, 282:1623–1624.
Kalleborn JC, Price TG, Carrico R, et al.: Emergency department management of occupational exposures: cost analysis of rapid HIV test. Infect Control Hosp Epidemiol 2001, 22:289–293.
Walensky RP, Paltiel AD: Rapid HIV testing at home: does it solve a problem or create one? Ann Intern Med 2006, 145:459–462.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franco-Paredes, C., Tellez, I. & del Rio, C. Rapid HIV testing: A review of the literature and implications for the clinician. Curr HIV/AIDS Rep 3, 169–175 (2006). https://doi.org/10.1007/s11904-006-0012-3
Issue Date:
DOI: https://doi.org/10.1007/s11904-006-0012-3